Original Article
Copyright copy;2010 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 28, 2010; 16(36): 4549-4557
Published online Sep 28, 2010. doi: 10.3748/wjg.v16.i36.4549
Table 1 Immunostains used in the study
AntibodyClone/PADCompany and Cat. No.Staining patternDilution used
CD31JC70ADako, M0823Membrane1:50
CD34QBEnd/10Zymed, ZM-0046Membrane1:25
Factor VIIIPolyclonal serumZymed, ZA0111Cytoplasmic1:50
CK8C51Zymed, ZM-0310Cytoplasmic1:100
CK18DC-10Zymed, ZM-0073Cytoplasmic1:100
Table 2 Clinical presentations
CaseSex/agePresenting featuresSolitary or multicentric lesion; site/size (cm)Leuko cytosisAnemiaThrombocytosisHyperbiliru binemiaAbnormalliverfunctionIncrease AFPHistological typeTreatmentFollow-up (yr)
1M/2 moAMS; LL; 9.0 × 9.0 × 7.5NoYesYesNoNoNAICRAlive, 9
2F/17 dAbdominal distentionS; LL and RL; 11.0 × 8.0 × 6.5NoNoNoYesYesNAIBOAlive, 6.75
3F/2 moAM, neonatal pneumoniaS; LL; 5.0 × 3.5 × 2.0YesNoYesNAYesYesICRAlive, 6.25
4F/6 moAMS; LL; 11.0 × 10.0 × 8.0NoYesYesNANoNAICRAlive, 5
5F/5 yrAbdominal pain, dyspneaM; LL and RL; Oblique diameter of right hepatic: 9.7YesNoYesNoYesNAIIBOAlive, 4
6M/5 moAMS; LL; 10.5 × 7.5 × 7.0YesYesYesNANoNAIICRAlive, 3.75
7F/6 moAMS; RL; 10.0 × 10.0 × 8. 0NoYesNoNoNoYesICRAlive, 3.5
8F/3 yrJaundice, feverS; LL, RL and CL; 13.8 × 9.0 × 7.7YesYesNoNAYesNoIICRAlive, 2.25
9F/5 moAMS; RL; 6.2 × 6.0 × 3.5NoNoNoNoNoYesICRAlive, 1.5
10F/2 moAMS; CL; 6.0 × 5.0 × 4.0NoYesYesNoYesYesIBOAlive, 0.25
11F/AFAMS; RL; 8.2 × 6.5 × 7.8NANANANANANAIAborted
12M/AFAMS; LL; 7.6 × 7.4 × 7.2NANANANANANAIAborted